Novavax Aktie
5,24
EUR
+0,11
EUR
+2,10
%
5,94
USD
+0,52
USD
+9,49
%
vorbörslich
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 6 | 3 | 0 | 137,65 GBP | +35,51% |
| Bayer | 1 | 8 | 0 | 25,29 EUR | +22,29% |
| BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +36,42% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 3 | 5 | 2 | 45,17 EUR | +7,75% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 45,50 EUR | +23,98% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +156,98% |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +12,76% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 30,40 USD | +38,75% |
| Roche AG (Genussschein) | 3 | 3 | 3 | 285,88 CHF | +14,49% |
| Sanofi S.A. | 6 | 3 | 0 | 115,50 EUR | +28,94% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |